DoW Pancreatic Cancer Research Program, Translational Research Partnership Award
Grant Opportunity Analysis
The Department of the Army’s USAMRAA is offering the FY26 Pancreatic Cancer Research Program Translational Research Partnership Award to support collaborative translational research that advances promising pancreatic cancer ideas toward clinical application. The award is intended for partnerships among clinicians, population scientists, applied scientists, and basic scientists, and it can support retrospective tissue analysis, correlative studies, and pilot clinical trials while excluding large-scale clinical trials. Applications must include at least one participant with pancreatic cancer research or patient-care expertise, two principal investigators serving as Initiating PI and Partnering PI, preliminary data showing feasibility, and work aligned to at least one FY26 PCARP focus area. The program lists about $6.6 million for six awards, with a maximum of $1.1 million over three years, and the application deadlines are July 7, 2026 for the pre-application and October 7, 2026 for the full application.